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Introduction
Blau syndrome is a rare autoinflamattory granulomatous
disease and inherited as autosomal dominant.The classical
triad of Blau syndrome is granulomatous dermatitis, sym-
metric arthritis and recurrent uveitis. However, all of these
findings may not be together in the patients. In the major-
ity of patients, the disease is characterized by early onset
that usually before 3-4 years of age. The ocular findings of
Blau syndrome ocur usuaaly after the articular and skin
findings.
Objectives
Our aim is to describe a new mutation of Blau syndrome
here. The defective gen of Blau syndrome is located
16q12.2-13 locus and NOD2 gen is found in this locus. So
far, ten NOD2 mutations have been described that causes
Blau syndrome. In addition, seven NOD2 mutations have
been described that may be associated with Blau syn-
drome. These mutations are heterozygous state mostly.
Methods
Five years old male patient had developed papular rash
that lasted one year at 5 month old, bilateral knee and
ankle arthritis at 4 year old and right anterior uveitis at
5 year old. His papular rush and anterior uveitis was com-
patible with granulomatous vasculitis and granulomatous
uveitis, respectively.
Results
Blau syndrome gen studies revealed heterozygous mis-
sense NOD2 mutation ( P507S [(c.1519C>T)].
Conclusion
Up to date, 10 Blau-associated genetic mutations have
been identified within thisgene, almost in heterozygous
state. Two of these mutations (R334Q and R334W)
account for more than 50% of the mutated alleles. The
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